Do we need yet another journal?

Vincent T DeVita Jr

doi:10.1038/ncponc0027 | Full Text | PDF (36K)

The impact of epidermal-growth-factor-receptor mutations in response to lung-cancer therapy

Jonathan E Dowell and John D Minna

doi:10.1038/ncponc0007 | Full Text | PDF (57K)

When is a genomic classifier ready for prime time?

Richard Simon

doi:10.1038/ncponc0006 | Full Text | PDF (53K)

Risk of brain tumors in metastatic breast cancer

doi:10.1038/ncponc0002 | Full Text | PDF (49K)

Brachytherapy for cervical cancer

doi:10.1038/ncponc0003 | Full Text | PDF (49K)

Bone complications in prostate cancer

doi:10.1038/ncponc0004 | Full Text | PDF (54K)

Towards tailored chemotherapy for NSCLC

doi:10.1038/ncponc0005 | Full Text | PDF (43K)

Statin therapy: long-term mortality and cancer incidence

doi:10.1038/ncponc0015 | Full Text | PDF (43K)

Genetic basis of drug resistance in childhood ALL

doi:10.1038/ncponc0016 | Full Text | PDF (49K)

Health-related quality of life in breast cancer

doi:10.1038/ncponc0017 | Full Text | PDF (49K)

The blood–testis barrier in health and disease

doi:10.1038/ncponc0018 | Full Text | PDF (54K)

Early promise for esophageal cancer diagnosis

doi:10.1038/ncpgasthep0010 | Full Text | PDF (46K)

Occult tumor cell detection in colorectal cancer

doi:10.1038/ncpgasthep0011 | Full Text | PDF (54K)

Hepatocellular carcinoma in the elderly

doi:10.1038/ncpgasthep0012 | Full Text | PDF (49K)

New device aids colon surgery

doi:10.1038/ncpgasthep0013 | Full Text | PDF (49K)

Benefits of exercise in radiotherapy

doi:10.1038/ncpuro0015 | Full Text | PDF (49K)

Predicting clinical outcome in prostate cancer

doi:10.1038/ncpuro0020 | Full Text | PDF (48K)

Can combined whole brain radiation therapy and radiosurgery improve the treatment of single brain metastases?

Jay S Loeffler

doi:10.1038/ncponc0008 | Full Text | PDF (58K)

Does concurrent postoperative radiotherapy and chemotherapy in head and neck cancer improve patient outcome?

Sue S Yom and David I Rosenthal

doi:10.1038/ncponc0009 | Full Text | PDF (61K)

Can dexrazoxane reduce myocardial injury in anthracycline-treated children with acute lymphoblastic leukemia?

Jeffrey H Silber

doi:10.1038/ncponc0023 | Full Text | PDF (87K)

Are symptoms reliable as an indication for the necessity of bone scans in lung cancer metastases?

Rebecca Wong

doi:10.1038/ncponc0022 | Full Text | PDF (55K)

Is fulvestrant more effective than tamoxifen for treating ER-positive breast cancer in postmenopausal women?

Vinod Raina

doi:10.1038/ncponc0010 | Full Text | PDF (59K)

Can EPO reduce blood transfusion requirements during induction therapy for high-risk neuroblastoma?

Mario Cazzola

doi:10.1038/ncponc0001 | Full Text | PDF (57K)

Can exemestane improve adjuvant treatment for postmenopausal women with primary breast cancer?

Lisa Hutchinson

doi:10.1038/ncponc0021 | Full Text | PDF (56K)

Long-term survivors of childhood cancers: what knowledge have we gained?

Mike M Hawkins

doi:10.1038/ncponc0020 | Full Text | PDF (88K)

Allogeneic hematopoietic stem-cell transplantation: the next generation of therapy for metastatic renal cell cancer

Manit Arya, David Chao and Hitendra RH Patel

doi:10.1038/ncponc0019 | Full Text | PDF (97K)

Targeting angiogenesis in cancer: clinical development of bevacizumab

David J Kerr

doi:10.1038/ncponc0026 | Full Text | PDF (87K)

Technology Insight: emerging techniques to predict response to preoperative chemotherapy in breast cancer

Lajos Pusztai and Luca Gianni

doi:10.1038/ncponc0025 | Full Text | PDF (167K)